We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+24.59%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$59.9B
AUM Growth
+$12.2B
(+25%)
Cap. Flow
+$2B
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
3,213
New
281
Increased
1,628
Reduced
1,147
Closed
147
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$134M |
| 2 |
Microsoft
MSFT
|
+$119M |
| 3 |
Apple
AAPL
|
+$87.6M |
| 4 |
AbbVie
ABBV
|
+$61.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$54.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$92.9M |
| 2 |
RTN
Raytheon Company
RTN
|
+$71.6M |
| 3 |
CY
Cypress Semiconductor
CY
|
+$23.6M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$12.9M |
| 5 |
Domino's
DPZ
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.43% |
| 2 | Healthcare | 14.28% |
| 3 | Financials | 13.11% |
| 4 | Consumer Discretionary | 10.94% |
| 5 | Communication Services | 9.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AAMI
1651
Acadian Asset Management
AAMI
$3.19B
| $2.3M | ﹤0.01% |
184,648
+61,657
| +50% | +$505K |
|
1652
Towne Bank
TOWN
$3.42B
| $2.29M | ﹤0.01% |
121,781
+1,954
| +2% | +$36.3K |
|
|
MNR
1653
DELISTED
Monmouth Real Estate Investment Corp
MNR
| $2.29M | ﹤0.01% |
158,207
-22,673
| -13% | -$294K |
|
|
AQUA
1654
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $2.28M | ﹤0.01% |
122,409
+19,065
| +18% | +$315K |
|
|
MDLA
1655
DELISTED
Medallia, Inc.
MDLA
| $2.28M | ﹤0.01% |
90,226
+29,572
| +49% | +$706K |
|
|
VSTO
1656
DELISTED
Vista Outdoor Inc.
VSTO
| $2.28M | ﹤0.01% |
157,482
-17,566
| -10% | -$176K |
|
1657
Vanda Pharmaceuticals
VNDA
$302M
| $2.27M | ﹤0.01% |
198,880
+23,350
| +13% | +$264K |
|
1658
BOK Financial
BOKF
$8.74B
| $2.27M | ﹤0.01% |
40,141
-510
| -1% | -$26.1K |
|
1659
CBIZ
CBZ
$2.96B
| $2.27M | ﹤0.01% |
94,486
+4,045
| +4% | +$91.8K |
|
|
AGR
1660
DELISTED
Avangrid, Inc.
AGR
| $2.26M | ﹤0.01% |
53,908
+3,390
| +7% | +$145K |
|
|
SFIX
1661
Stitch Fix
SFIX
$560M
| $2.26M | ﹤0.01% |
90,673
+33,852
| +60% | +$668K |
|
1662
Abercrombie & Fitch
ANF
$5B
| $2.26M | ﹤0.01% |
212,046
-18,798
| -8% | -$205K |
|
1663
OFG Bancorp
OFG
$2.21B
| $2.25M | ﹤0.01% |
168,662
-12,435
| -7% | -$150K |
|
|
HSKA
1664
DELISTED
Heska Corp
HSKA
| $2.25M | ﹤0.01% |
24,121
+1,392
| +6% | +$107K |
|
1665
Assured Guaranty
AGO
$3.34B
| $2.25M | ﹤0.01% |
92,013
-7,075
| -7% | -$193K |
|
1666
Acushnet Holdings
GOLF
$5.45B
| $2.25M | ﹤0.01% |
64,519
+1,342
| +2% | +$39.8K |
|
1667
Dine Brands
DIN
$452M
| $2.24M | ﹤0.01% |
53,184
-2,514
| -5% | -$101K |
|
|
ESPR
1668
DELISTED
Esperion Therapeutics
ESPR
| $2.24M | ﹤0.01% |
43,609
+5,462
| +14% | +$229K |
|
|
PTLA
1669
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.23M | ﹤0.01% |
124,022
+14,387
| +13% | +$200K |
|
1670
Gray Television
GTN
$552M
| $2.22M | ﹤0.01% |
159,207
+14,583
| +10% | +$187K |
|
1671
Veeco
VECO
$3.23B
| $2.21M | ﹤0.01% |
163,882
-17,107
| -9% | -$196K |
|
1672
Oceaneering
OII
$4.77B
| $2.21M | ﹤0.01% |
345,105
-36,653
| -10% | -$193K |
|
1673
CTS Corp
CTS
$1.89B
| $2.2M | ﹤0.01% |
109,670
-10,581
| -9% | -$227K |
|
1674
Denali Therapeutics
DNLI
$3.97B
| $2.2M | ﹤0.01% |
90,915
+24,985
| +38% | +$587K |
|
1675
Artivion
AORT
$1.32B
| $2.2M | ﹤0.01% |
114,598
-4,761
| -4% | -$101K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2020 Portfolio in Review
As of Q2 2020, RhumbLine Advisers held 3,213 positions worth $59.9B, up 25% from $47.7B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers deployed $2B of net new capital in Q2 2020, opening 281 new positions and adding to 1,628 existing holdings. Its largest new stake was Otis Worldwide: 701,378 shares worth $39.9M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was iShares Core S&P Mid-Cap ETF, an estimated $12.9M trimmed.
- RhumbLine Advisers's largest Q2 2020 buy was Otis Worldwide: 701,378 shares worth $39.9M.
- RhumbLine Advisers added most to Amazon in Q2 2020, an estimated $134M increase.
- RhumbLine Advisers's biggest Q2 2020 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $12.9M.
- RhumbLine Advisers fully exited Allergan plc in Q2 2020, selling an estimated $92.9M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $59.9B portfolio in Q2 2020.
- RhumbLine Advisers opened 281 new positions and closed 147 in Q2 2020.
- RhumbLine Advisers's portfolio value rose 25% quarter-over-quarter to $59.9B.
Based on RhumbLine Advisers's 13F filing for Q2 2020, filed 13 Aug 2020.